<DOC>
	<DOCNO>NCT00850941</DOCNO>
	<brief_summary>The goal clinical research study create registry ( research database ) clinical data patient receive radiation therapy , without hormone therapy , treat prostate cancer come back surgical removal prostate . This treatment standard actual treatment part protocol . Researchers want collect data use registry learn long-term status prostate cancer treatment .</brief_summary>
	<brief_title>Radiation Therapy Rising Prostate Specific Antigen ( PSA ) Post-prostatectomy</brief_title>
	<detailed_description>Standard Treatment : If find eligible choose take part , enrol study . Study participant receive standard radiation treatment prostate cancer , come back surgical removal prostate . If PSA level lower , receive radiation alone . If PSA level high , receive hormone therapy addition radiation . You sign separate consent form describe treatment risk detail . This study require treatment . The main purpose study data gathering use questionnaires tissue banking . Follow-Up Tests : After treatment ( radiation without hormone therapy ) , receive routine follow-up care . The result follow routine test enter registry : - After complete radiation , blood ( 1 tablespoon ) drawn check PSA level every 3 month first 2 year , every 6 month next 3 year , every year . - If receive hormone therapy , additional blood ( 1 tablespoon ) drawn check level testosterone hormone . These blood test check testosterone level draw time PSA blood test , testosterone level normal range . - Every 6 month first 2 year complete radiation , physical exam digital rectal exam . After , physical exam digital rectal exam repeat every year . Information Collection : While study , long-term basis , researcher collect information medical record status disease . This information enter registry . To identify , registry use medical record number instead name identify information . The registry password-protected keep data secure . Length Study Participation : You study long agree keep take part . If go study , data longer enter registry . This investigational study . All test , procedure , treatment relate study part routine care . Up 500 patient take part study . All enrol MD Anderson , Spartanburg Regional Healthcare System , and/or MD Anderson Cancer Center Albuquerque .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Adenocarcinoma prostate definitively treat radical prostatectomy . 2 . Patients must evidence nodal distant metastasis clinical radiologic stag include bone scan CT scan MRI abdomen pelvis . Patients clinical radiographic local recurrence eligible . In patient Gleason score less equal 7 PSA less equal 1 , CT MRI abdomen recommend require . 3 . Rising PSA prostatectomy define least 2 consecutive rise . If total PSA &lt; 0.2 ng/ml , surgical pathology must also show extracapsular extension , positive margin , seminal vesicle involvement . 4 . Total PSA &lt; 5 ng/ml within 12 week prior start radiation hormone therapy . 5 . Patients PSA great equal 0.5 ng/ml may 3 month LHRH agonist antiandrogen immediately prior enrollment . 6 . All patient must serum testosterone 150 ng/dl great document prior initiation hormone therapy . Alternatively , patient without documentation serum testosterone prior initiation hormone therapy prior hormone therapy within 24 month precede initiation hormone therapy . 1 . Patients pathologically positive pelvic lymph node prostatectomy . 2 . Patients positive prostascint scan outside prostatic fossa . 3 . Any chemotherapy , immunotherapy , biological therapy cancer within 90 day enrollment . 4 . Hormone therapy ( specifically LHRH agonist antagonist , nonsteroidal steroidal antiandrogens ) 6 month duration time past prostate cancer . 5 . Contraindications external beam radiation therapy include previous pelvic radiation , inflammatory bowel disease history collagen vascular disease .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Registry</keyword>
	<keyword>Research Database</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Casodex</keyword>
	<keyword>Flutamide</keyword>
	<keyword>Goserelin Acetate</keyword>
	<keyword>Leuprolide Acetate</keyword>
	<keyword>Radiation</keyword>
	<keyword>PSA</keyword>
	<keyword>Post-prostatectomy</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Prostate Specific Antigen</keyword>
	<keyword>Adenocarcinoma</keyword>
	<keyword>Radical Prostatectomy</keyword>
	<keyword>Bicalutamide</keyword>
	<keyword>Zoladex</keyword>
	<keyword>Lupron Depot</keyword>
	<keyword>Tissue banking</keyword>
	<keyword>Hormones</keyword>
</DOC>